Filtering by
- All Subjects: Human Papilloma Virus
- All Subjects: Residential Treatment
- Creators: Velasquez, Donna
Study Design: Ten health care providers from Vaccines for Children (VFC) clinics in New Mexico were included in this pretest/posttest study. Providers were given a questionnaire adapted from the Determinants of Intent to Vaccinate (DIVA) questionnaire. Only two subscales were utilized for this project (total of 10 items): Adaptation to the Patient’s Profile and General Practitioner’s Commitment to the Vaccine Approach. Martinez et al. (2016) suggest that PCP’s commitment to the vaccination approach” can be used as a stand-alone tool with a Cronbach’s alpha > .70. Following the pretest, which served as consent, providers viewed a short, four video series addressing common barriers to the HPV vaccine, followed by the same questionnaire. First and second dose rates of the HPV vaccine were measured prior to the intervention and three months post intervention using the New Mexico Immunization Information System (NMSIIS).
Results: A Wilcoxon Ranks test was used for statistical analysis of the survey responses. Alpha was set at ≤ .10. Four of the 10 questions were statistically significant for increasing provider intent to vaccinate. HPV first dose rates increased in all three clinics and second dose rates increased in two out of the three clinics.
Conclusions: Web-based education is a successful intervention for increasing
provider intent to vaccinate and first and second dose HPV administration rates. Not only can the intervention be used for the HPV vaccine, but to help increase administration rates of all other vaccines.
Opioid overdose is now the leading cause of unintentional injury related mortality in the U.S. with two people dying each day as a result of opioid overdose in Arizona. Among patients treated for opioid use disorder, chronic pain is frequently cited as the reason for opioid use. Treatment of chronic pain with long-term use of opioids is linked to increased medication tolerance, worsened pain sensitivity, and psychological symptoms. Acceptance of chronic pain is the individual’s ability to be willing to endure pain and their ability and willingness to participate in activities despite experiencing chronic pain. Increased acceptance of chronic pain has been shown to lower pain intensity, promote recovery of individuals’ emotional and physical abilities, and lessen use of pain medication including opioids.
Purpose: The purpose of this evidence-based practice project was to examine the feasibility of using acceptance of chronic pain, pain severity, and pain interference as measures to evaluate the effectiveness of a multimodal residential treatment program for opioid abuse.
Methods: Two surveys, the CPAQ and BPI were administered shortly after admission (T1) and after 21-25 days (T2) to evaluate project feasibility.
Results: Six participants were enrolled. Three participants completed T1 and T2 surveys. Three participants were lost to follow-up. Mean scores for Chronic Pain Acceptance were T1 = 79 (SD = 17.0) and T2 = 78.67 (SD = 5.0). All surveys were easy to administer and participants answered all questions.
Conclusion: Chronic pain acceptance may be a feasible and meaningful measure with which to evaluate residential treatment programs. Further research is needed to evaluate acceptance of chronic pain with long-term opioid abstinence and overdose deaths.